
Case Information
Client: Química Suiza
Industry: Pharmaceutical
Market Position: Regional Leader
Location: Peru, Bolivia, Ecuador
Service: Branding & 3D Modeling
Publication Year: 2021

1. Executive Summary
Química Suiza, a prominent pharmaceutical and consumer goods distributor with operations in Peru, Bolivia, and Ecuador, sought to enhance the branding and visual presentation of two pharmaceutical product lines: Feranin and Quilab. The challenge was to modernize and refine the packaging and presentation for a successful product launch. Boltek Media developed a photorealistic 3D rendering and branding expansion strategy, resulting in a visually impactful launch, improved market perception, and versatile assets for future brand applications.
2. About the Client
Química Suiza is a leading distributor of pharmaceutical and consumer products, committed to delivering top-tier solutions to the Latin American market. With a reputation for excellence, the company operates across Peru, Bolivia, and Ecuador, ensuring high-quality standards and innovation in healthcare and retail sectors. The company aimed to reinforce its brand presence and improve the presentation of new pharmaceutical product lines for a successful market introduction.
Key client Attributes:
-
Regional Market Leader: Strong presence across three Latin American countries.
-
Commitment to Innovation: Consistently integrates advanced design and packaging solutions.
-
Quality Assurance Focus: Ensures top-tier pharmaceutical and consumer goods distribution.
3. The Challenge
Despite its solid market position, Química Suiza faced a challenge in effectively presenting the launch of Feranin and Quilab. The existing branding did not fully convey the premium quality of these pharmaceutical products, and traditional photography had limitations in flexibility and impact. To secure a strong market entry, it was essential to develop a modern, adaptable, and visually striking branding approach.
Key Obstacles:
-
Lack of High-Impact Product Visuals: Existing packaging did not convey innovation or market leadership.
-
Limited Flexibility in Branding Assets: Traditional photography restricted adaptability for digital and physical applications.
-
Need for a Cohesive Presentation Strategy: A structured approach was necessary to unify branding and product perception.
The absence of an optimized presentation strategy risked weakening the brand’s competitive positioning in the pharmaceutical sector.
Deficient Metrics Before Implementation:
Brand Recognition Rate:
Market Differentiation Score:
Digital Presentation Quality:
Product Appeal Perception:
4. Strategy and Solution Implemented
Boltek Media employed a cutting-edge visual and branding strategy to position Feranin and Quilab as modern, high-quality pharmaceutical products. Our solution included photorealistic 3D product renderings that enhanced visual appeal and provided flexible, high-resolution assets for multiple marketing applications. Additionally, we expanded the existing corporate branding guidelines to seamlessly integrate these product lines. Through a structured design approach, we ensured consistency across digital and print materials while maintaining a compelling, premium aesthetic.
Key Strategic Steps:
1
Photorealistic 3D Modeling:
2
Brand Expansion Strategy:
3
Visual Impact Optimization:
4
Versatile Digital Applications:



5. Results and Metrics
The execution of this branding and visual enhancement strategy resulted in a significant uplift in market perception and product appeal. The high-quality renderings were utilized across various brand applications, contributing to an impactful and successful launch of Feranin and Quilab. The project established a scalable approach for future product visualizations within Química Suiza’s portfolio.